About EndoAxis
EndoAxis is a Healthcare company based in Beverly Hills (United States) founded in 2020 by Microbiome Labs, Guy Citrin, and Tom Bayne. Provider of personalised nutritional supplements and lifestyle remedies to enhance patient health outcomes. EndoAxis has raised $550 thousand across 2 funding rounds. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. EndoAxis offers products and services including AI Hormonal Diagnostics and Personalized Supplements. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Personalized. Its competitors include Viome, Flore and Elo Health; 3 of its 3 listed competitors have raised funding.
Company details
EndoAxis was founded in 2020 and is headquartered in Beverly Hills, United States. Operations focus on the health and wellness sector, where lab tests for diagnosing hormone dysfunction are conducted. Personalised treatment plans, including suggested formulations, are generated based on individual patient profiles to support nutritional and lifestyle interventions. Services are tailored to improve health outcomes through targeted remedies.
- Headquarters Beverly Hills, United States
- Founders Microbiome Labs, Guy Citrin, Tom Bayne
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website endoaxis.com
- Social Instagram
- Legal Name Endoaxis Labs Llc
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Total Equity Funding$550K (USD)
in 2 rounds
- Latest Funding Round$250K (USD), Seed
Aug 2025
Associated legal entities of EndoAxis
EndoAxis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Products & Services of EndoAxis
EndoAxis offers a comprehensive portfolio of products and services, including AI Hormonal Diagnostics and Personalized Supplements.
AI platform for analyzing and interpreting hormone lab results accurately
Custom formulations based on lab data to support hormone balance effectively
Funding Insights of EndoAxis
EndoAxis has successfully raised a total of $550K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $550,000
- Total Rounds 2
- Last Round Seed — $250,000
- First Round $300,000
(Dec 2024)
All 2 funding rounds of EndoAxis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $250,000 | Seed | – | – | – |
| Dec 2024 | $300,000 | Seed | – | – | – |
Board of directors of Ironsource India Private Limited (EndoAxis)
Ironsource India Private Limited is the primary company behind EndoAxis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
People of EndoAxis
3 people are tracked at EndoAxis (3 in leadership).
| Name | Role | Group |
|---|---|---|
Microbiome Labs | Co-Founder & CSO | Leadership |
Guy Citrin | Co-Founder & CMO | Leadership |
Tom Bayne | Co-Founder | Leadership |
Complete people profiles for EndoAxis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of EndoAxis
Figures of Ironsource India Private Limited, the primary company behind EndoAxis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for EndoAxis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of EndoAxis
3 dated milestones of EndoAxis across 5 years, from founding to its latest funding, stage changes and deals.
- Founded EndoAxis is founded.
- Funding First funding round of $300K.
- Funding Latest funding round, Seed, of $250K.
Competitors of EndoAxis
EndoAxis has 3 listed competitors in our database, 3 of them funded. They include Viome, Flore and Elo Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| flore.com | 2016 | San Diego, United States | $21.12M | Customized probiotics for gut health are provided via stool analysis. | ||
| elo.health | 2020 | San Francisco, United States | $18.49M | 11 | Personalized supplements are delivered based on biochemical analysis. |
Detailed competitors of EndoAxis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EndoAxis
The website of EndoAxis (endoaxis.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▼ 26.3% vs previous month
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as EndoAxis (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Endoaxis
Complete news archive for EndoAxis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoAxis
EndoAxis was founded in 2020 and raised its 1st funding round 4 years after it was founded.
EndoAxis is headquartered in Beverly Hills, United States. It is registered at Beverly Hills, California, United States.
EndoAxis is a funded company, having raised a total of $550K across 2 funding rounds to date. The company's 1st funding round was a Seed of $300K, raised on Dec 2024.
The primary company behind EndoAxis, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
EndoAxis was founded in 2020 and is headquartered in Beverly Hills, United States. Operations focus on the health and wellness sector, where lab tests for diagnosing hormone dysfunction are conducted. Personalised treatment plans, including suggested formulations, are generated based on individual patient profiles to support nutritional and lifestyle interventions. Services are tailored to improve health outcomes through targeted remedies.
EndoAxis's top competitors include Viome, Flore and Elo Health.
EndoAxis offers AI Hormonal Diagnostics and Personalized Supplements.
EndoAxis operates through Ironsource India Private Limited.
The legal entities of EndoAxis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.